




Searching News Database: Targacept
HSMN NewsFeed - 15 Nov 2012
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
HSMN NewsFeed - 3 Mar 2011
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
HSMN NewsFeed - 5 Apr 2010
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors
HSMN NewsFeed - 14 Dec 2006
LigoCyte Pharmaceuticals Announces the Addition of Dr. Donald deBethizy to Their Board of Directors
LigoCyte Pharmaceuticals Announces the Addition of Dr. Donald deBethizy to Their Board of Directors
HSMN NewsFeed - 9 Nov 2006
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
HSMN NewsFeed - 24 Oct 2006
Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors
Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors
HSMN NewsFeed - 13 Oct 2006
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
HSMN NewsFeed - 19 May 2006
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
Additional items found! 3

Members Archive contains
3 additional stories matching:
Targacept
(Password required)
Targacept
(Password required)